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An Assessment of New
Sperm Tests for Male Infertility
Alessandro Natali and Paul J. Turek
The routine semen analysis, although used for more than 50 years, fails to accurately distinguish between fertile and
infertile men. As a consequence, many tests of sperm function (TSF) have been developed. This review discusses both
older and newer diagnostic TSF. It outlines the principles underlying each assay and reviews aggregate clinical data to
determine its current relevance and utility. It concludes that the relevance of many older TSF is questionable, with the
wide acceptance of intracytoplasmic sperm injection (ICSI). Newer TSF have the potential to deliver more clinically
relevant information but require more extensive study to better understand their predictive role in the ICSI
era. UROLOGY 77: 1027–1034, 2011. © 2011 Elsevier Inc. All rights reserved.
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TIn addition to the medical history and physical exam-ination, the conventional semen analysis has been anessential laboratory test for the evaluation of male
fertility for at least 50 years. However, the idea that
fertility can be defined by threshold values of semen
parameters is a concept that is fundamentally flawed.1
Although not a true measure of fertility, the semen
analysis, if abnormal, suggests that the probability of
achieving fertility is lower than normal.2 Because of
biological variability, two semen analyses are generally
needed, performed with two to three days of sexual ab-
stinence and evaluated in a standardized fashion.2 Rec-
gnized normal values for semen parameters are given in
able 1 in agreement with the latest recommendations
y the World Health Organization (WHO).2 Tradition-
lly, (except for the latest WHO recommendations),
hese references are derived by expert consensus and not
y prospective clinical trials and thus their true relation-
hip to male fertility is unclear. In addition, the definition
f what constitutes “normal” semen parameters is con-
tantly challenged. A meta-analysis of 29 US studies of
emen quality from 9612 fertile, or presumably fertile,
en suggested that a sperm concentration of 98 mil-
ion/mL is normal.3 Although sperm motility is consid-
red the “best” predictor of fertility, normal sperm mo-
ility ranges from 53% to 62%.4 Thus, simply deriving
“normal” semen parameters has been a prohibitively
lengthy and inconclusive process to date.
Finally, other biological variables affect the clinical
utility of the semen analysis. In addition to wide intra-
individual variation, seasonal5 and geographic variation4
further complicate the performance of the semen analysis
as a fertility measure. As examples, within-subject, in-
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tion and motility are estimated at 44.7% and 15% in one
study.1 Thus, even with excellent quality control, wide
biological variation in semen quality profoundly chal-
lenges the notion that the conventional semen analysis
can accurately assess male fertility.
OLDER ADJUNCTIVE SPERM TESTS
Because of the need to more precisely characterize nor-
mal fertile semen, adjunctive semen testing has become
popular (Figure 1). The concept behind developing ad-
junctive sperm tests is that the functional competence of
sperm matters for fertility. Although such testing has
fallen out of favor in the last decade with the rise of
intracytoplasmic sperm injection (ICSI), the idea that
not all sperm used with ICSI are the same has reignited
interest in adjunctive sperm testing.
Sperm Morphology
One of the oldest adjunctive sperm tests is the formal
evaluation of sperm shape, termed morphologic assess-
ment.6 Several descriptive systems exist to evaluate mor-
hology, and within each system, sperm are designated
ormal or abnormal based on specific criteria. It is be-
ieved that sperm morphology may correlate with a man’s
ertility potential as reflected by in vitro fertilization
IVF) success in case cohort studies.7 More recently,
however, the ability of sperm morphology to distinguish
candidates who are at risk of failing IVF has been called
into question.8 In addition, test reliability and reproduc-
bility are low and normal biological variation may be
igh, all of which complicate and reduce the perfor-
ance of sperm morphology as a diagnostic test.
perm Penetration Assay (SPA)
his bioassay, first described by Yanagimachi and col-eagues in 1976, examines the ability of sperm to pene-
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ttrate zona-free hamster eggs.9 The assay was designed to
analyze four steps in the fertilization process: capacita-
tion, acrosome reaction, fusion with the oocyte vitelline
membrane, and sperm decondensation. In limited stud-
ies, the SPA has been shown to correlate with fertiliza-
tion rates in vitro. In a study by Soffer et al., in which 241
infertile couples scheduled for IVF were assessed, the
SPA predicted fertilization with high negative (74%) and
positive (82%) predictive values and with excellent spec-
ificity (0.96).10 Limitations to the clinical utility of the
PA include the use of hamster oocytes, its labor-inten-
ive nature and expense, the fact that it is technically
emanding to perform, and that it has significant issues of
ssay standardization.1
Hemizona Assay (HZA)
The HZA, first described by Burkman et al. in 1988,
was introduced to examine the binding of sperm to the
human-oocyte zona pellucida.11 Quantification of
sperm-zona binding uses salt-stored human hemizonae
and is a relatively sophisticated and involved bioassay.
It was developed to predict sperm fertilization poten-
tial for IVF treatment. Arslan and colleagues evaluated
the value of the HZA to predict pregnancy in 82
couples with unexplained or male factor infertility
after 313 intrauterine insemination (IUI) cycles.12
The main outcome measures evaluated were hemizona
index (HZI) and clinical pregnancy rate. Overall, pa-
tients with a HZI value of 30 had a significantly
lower pregnancy rate compared with patients with a
HZI of 30 (11.1% vs 40.6%, respectively; P .05),
and the relative risk for failure to conceive was 1.5 (CI,
1.2–1.9). User receiver operating characteristics curves
over the range of HZI scores (0 – 60), the duration of
infertility, and the HZI score were significant determi-
nants of conception. In addition, the negative and
positive predictive values of the HZA for clinical preg-
nancy were 93% and 69%, respectively. This assay,
although complicated, is significant in that it can
predict sperm binding to the oocyte and can delineate
sperm deficiencies of this nature. This matters because
defective sperm-zona binding is a common cause of
IVF failure. HZA has not been sufficiently evaluated to
Table 1. Lower references limits (5th centile) for semen
characteristics (WHO 2010)
Volume (mL) 1.5
Concentration (106 sperm/mL) 15
Total sperm number (106/ejaculate) 39
Motility (% motile) 40 (a  b  c)
Forward progression 32 (a  b)
Morphology (% normal) 4
Viability/Vitality (% alive) 58%
White blood cells (106 sperm/mL) 1.0know whether it correlates with natural conception.12
1028Acrosome Reaction (AR)
This acrosome reaction is an exocytic secretory event
within the sperm head that releases proteolytic enzymes
for zona pellucida penetration and remodels the sperm
surface in preparation for oocyte fusion.1,13 It is triggered
by sperm-zona binding. The AR status of sperm is as-
sessed using fluorescent lectins that bind to the acrosomal
membrane or to the acrosomal contents. To differentiate
nonspecific from physiological ARs, the assay is com-
bined with a cell viability assessment. One limitation of
AR assays is that there is a measurable prevalence of
spontaneous AR in human sperm (4%), making corre-
lations to pregnancy outcomes difficult.1 Because of this,
AR induction with ionophores has been reported to
improve the dynamic range of the assay. Unfortunately,
using ionophores is a nonphysiological maneuver and
avoids the normal receptor-signal activation system that
is important to assess.
Progesterone, a hormone present in follicular fluid and
in the oocyte cumulus matrix, induces the acrosome
reaction and the development of hyperactive motility
patterns.14 This “physiological” agent has been used by
rausz et al.,14 who reported a significant correlation
between acrosome reaction induction with progesterone
and fertilization rate in vitro. In addition, impaired re-
sponsiveness of human sperm to progesterone has been
associated with reduced fertilization.15 These data suggest
sperm responsiveness to progesterone, as assessed by the
acrosome reaction, may predict fertilization.16 In sum-
mary, induced AR assays have value in explaining fertil-
ization failure in IVF cases, but have not been shown to
correlate with natural pregnancy rates.
Hyposmotic Swelling Test (HOS)
The HOS test, first described by Jeyendran in 1984, was
developed to evaluate the integrity of the sperm plasma
membrane.17 The test is based on the biology of osmosis
and the fact that fluid transport occurs across an intact
cell membrane until osmolar equilibrium is reached. In
test conditions, in which sperm are exposed to hypo-
osmolar fluid, the sperm expand, especially in the tail,
and produce characteristic morphologic changes. In the
original assay, the ability of sperm to swell correlated well
with its capacity to penetrate denuded hamster oocytes.17
Although simple and economical, HOS has not proven
useful clinically in the assessment of the fertilizing capac-
ity of sperm.18 It has however been valuable in noninva-
ively selecting viable sperm from a nonmotile popula-
ion for ICSI.19
Conclusions
Although innovative, older assays of sperm function are
not widely used in clinical medicine today. The combi-
nation of complexity, expense, lack of standardization,
and poor correlation to reproductive outcomes severely
limit their clinical utility. In addition, the information
learned may not significantly affect clinical decision mak-
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ling with the wide use of ICSI. In bypassing many of the
sperm requirements needed for egg fertilization (Fig. 1),
such as the AR, capacitation, sperm-zona binding and
penetration, and oocyte binding, ICSI effectively treats
most sperm deficiencies described in these assays. Despite
this, the development of new functional sperm assays is
important, becasue accurate, simple, and reliable tests of
sperm function can be valuable in predicting infertility
that may benefit the most from ICSI.
NEWER ADJUNCTIVE SPERM TESTS
Sperm DNA Fragmentation
Recently, the integrity of DNA packaging within sperm
chromosomes has been suggested as a biological correlate
of fertility.20 DNA fragmentation is characterized by both
ingle and double DNA strand breaks, and is particularly
requent in the sperm of subfertile men. However, it is
lso true that oocytes and early embryos can repair sperm
NA damage.21 Thus, the biological effect of damaged
sperm DNA depends on both the degree of sperm chro-
matin damage and the capacity of the early embryo to
repair it (Fig. 2).
Abnormal sperm chromatin structure or DNA dam-
age is thought to arise from four sources: (1) deficien-
cies in recombination during spermatogenesis, (2) ab-
normal spermatid maturation caused by protamination
Figure 1. Schematic illustration of the steps of the egg fert
Sperm morphology correlates with stages of egg cumulus a
Sperm penetration assay assesses the ability of sperm to bi
assay examines sperm binding to the zona pellucida. 4. Acr
sperm to penetrate cumulus and bind and penetrate the zo
and egg binding and egg penetration and fertilization at IVF
membrane, motility, and DNA integrity.disturbances, (3) abortive apoptosis, and (4) oxidative
UROLOGY 77 (5), 2011stress.20 Several assays have been developed to evalu-
te sperm DNA integrity, and exactly what is measured
ith each assay differs.20 In general, however, the
assays can be divided into three types: (1) assays to
determine sperm chromatin structure, (2) tests of
sperm DNA fragmentation, and (3) assays that assess
the sperm nuclear matrix.20
Probes to sperm chromatin structure. Chromatin struc-
tural probes apply sensitive nuclear dyes to examine
DNA integrity. Their cytochemical performance, how-
ever, is rather complex, because several factors influence
the DNA staining of chromatin by these dyes: (1) the
secondary structure of DNA, (2) the regularity and den-
sity of chromatin packaging, and (3) the binding of DNA
to chromatin proteins. Assays in this category include:
Acridine Orange (inexpensive, simple). Measures in situ
DNA susceptibility to acid-induced conformational helix-
coil transition22 (Fig. 3).
niline Blue (inexpensive, simple). Stains proteins in
oosely condensed chromatin23
Chromomycin a (inexpensive, simple). Competes with
protamines for association with DNA and staining relates
to the degree of protamination in mature sperm24
Toluidine blue (inexpensive, simple). Stains phosphate residues of
ion process that the older sperm function tests assess. 1.
gg binding, and egg penetration and fertilization at IVF. 2.
d penetrate the egg and decondense within it. 3. Hemizona
e reaction and the progesterone test assess the ability of
ellucida. 5. Hypo-osmotic swelling correlates with cumulus
Reactive oxygen species evaluation correlates with spermilizat
nd e
nd an
osom
na p
. 6.loosely packed and fragmented sperm nuclear DNA25
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he abSperm chromatin structural assay (SCSA) (expensive,
complex). Measures in situ DNA susceptibility to acid-
induced conformational helix-coil changes with acridine
orange fluorescence using automated cell sorting20 (Fig.
). SCSA is the most widely used assay, because associ-
tions with clinical outcomes after natural conception
nd assisted reproductive have been reported. The ad-
antages of SCSA are its robustness and small intra- and
nterassay variation.
ests of sperm DNA fragmentation. These tests focus
n the identification of single- or double-stranded DNA
trand breaks within sperm DNA. Assays included in this
Figure 2. Schematic illustration of the steps of the egg fert
Sperm DNA fragmentation correlates with sperm decondensa
of sperm to bind to the zona pellucida. 3. Ultrafine morpholog
and form embryos. 4. Chromatin decondensation assesses t
Figure 3. A common method of assessing sperm DNA fragm
is exposed to 488-nm laser light. AO intercalated into do
stranded DNA fluoresces red (color figure available online).ategory are:
1030n situ Nick translation. This assay quantifies the incor-
oration of biotinylated deoxyuridine triphosphate
dUTP) at single-stranded DNA breaks (SSBs) within
perm DNA in a reaction catalyzed by DNA polymer-
se I.24 Not widely used clinically, this assay lacks sen-
sitivity and correlative studies with fertility outcomes are
lacking.24
Terminal deoxynucleotidyl transferase mediated dUTP Nick
end labeling (TUNEL). This assay accurately detects
mainly double-stranded breaks (DSBs) in DNA through
the incorporation of dUTP at DNA breaks catalyzed by
terminal deoxynucleotidyl transferase. TUNEL is per-
on process that the newer sperm function tests assess. 1.
and form embryos. 2. Sperm HA binding examines the ability
elates with the ability of sperm to decondense within the egg
ility to sperm to decondense within the oocyte.
ation is to observe acridine orange (AO)-stained sperm that
-stranded DNA fluoresces green and AO bound to single-ilizati
tion
y corrent
ubleformed with flow cytometry, which allows efficient de-
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ftection of DNA fragmentation in a large population of
sperm.26 However, TUNEL evaluation by flow cytometry
ay underestimate actual sperm DNA fragmentation
ates. Combining TUNEL and propidium iodide nu-
lear staining can distinguish sperm from other round
ells in the semen, termed M540 bodies, that contain
mall but contaminating quantities of interfering frag-
ented DNA.27 A major disadvantage of TUNEL is
that it is relatively labor-intensive; standardized, clin-
ical kits are now available.28 In addition, there is no
clear clinical pregnancy outcome data that correlate
well with test results28.
ingle cell gel electrophoresis assay (COMET). This ap-
roach quantifies DNA SSBs and DSBs in single sperm
fter electrophoresis of fluorochrome-stained DNA.29
COMET is highly sensitive, but labor intensive and it
can be difficult to standardize comet tail length for re-
porting. In addition, assay correlation to clinical infertil-
ity outcomes is less apparent than with SCSA or TUNEL
methods.30
Sperm nuclear matrix assays. These assays are based on
he degree to which intact DNA deprived of chromatin
roteins is able to loop around the sperm nucleus
atrix.30 In support of this approach, it has recently
een shown that germ line mutations in nuclear matrix
roteins may lead to deficient DNA repair and chro-
atin disorganization.31 Two assays are allocated to
this category:
Sperm nuclear matrix stability. This assay assesses the
high-level DNA organization within the sperm nuclear
matrix and can detect aberrations in the ability of matrix
to organize DNA into loop-domains.30 This test is in the
evelopmental stages and clinical information regarding
utcomes is extremely limited.
perm chromatin dispersion. In this assay, fragmented
NA fails to produce the characteristic “halo” when it is
ixed with aqueous agarose after acid/salt treatment to
emove nuclear proteins.32 This assay is recent and has
limited verification in male infertility.32
Correlation of DNA integrity to ART outcomes. As-
says of sperm DNA damage have the potential to dis-
criminate among sperm of different quality. In general,
the mean percentage of sperm with abnormal DNA de-
naturation and abnormal DNA fragmentation in infertile
men is 25% and 28%, respectively, compared with fertile
men, at 10% and 13%, respectively.33 Assuming that
DNA damage arises solely from a failure to repair DNA
breaks introduced during spermatogenesis, it could be
expected that DNA damage would correlate well with
low sperm concentration or poor morphology. Alterna-
tively, if sperm DNA damage results mainly from the
adverse effects of reactive oxygen species (ROS), then
reduced sperm motility might be expected. Currently, the t
UROLOGY 77 (5), 2011relative contribution of these two sources of DNA dam-
age to sperm remains unknown.33
Several studies have examined the association of sperm
DNA integrity on reproductive outcomes after intrauter-
ine insemination (IUI), IVF and IVF/ICSI. To date,
there is little correlation between sperm DNA damage
and fertilization rates with either IVF or IVF/ICSI.34 This
makes sense, because neither fertilization nor early em-
bryo development are dependent on sperm DNA integ-
rity, because the embryonic genome is expressed after the
second cleavage division at the four-cell embryo stage.35
However, high levels of sperm DNA damage appear to
correlate inversely to successful pregnancy with IUI, IVF,
and IVF/ICSI.36 In the largest retrospective study to date,
Bungum et al.37 did not find increased pregnancy loss
ith high sperm DNA fragmentation rates with IVF/ICSI
ut did find a ten-fold lower risk of pregnancy with IUI.
his study also demonstrated significantly higher clinical
regnancy rates (52.9% vs 22.2%) and delivery rates
47.1% vs 22.2%) with IVF/ICSI compared with IVF in
ouples with high sperm DNA damage. Indeed, when the
NA fragmentation rate exceeded 27%, the odds ratio
or a positive reproductive outcome after ICSI compared
ith IVF was 8 for biochemical pregnancy, 4 for clinical
regnancy, and 3 for delivery. These data confirm earlier
bservations that IVF outcomes are affected more pro-
oundly than are IVF/ICSI results by DNA damage.36
Thus, as the literature on this assay accrues, the assess-
ment of sperm DNA integrity may become an important
predictor of pregnancy success in the setting of assisted
reproduction.
In what clinical scenarios should DNA fragmentation
assays be used? They can be considered in the following
cases:
● Unexplained or idiopathic infertility26
● When deciding between IUI or IVF/ICSI as therapeu-
tic options37
● In the setting of varicocele-associated infertility38
● Recurrent pregnancy loss39
Reactive Oxygen Species
Oxidative stress is a consequence of free radicals gener-
ated from cellular metabolism.40 Naturally occurring an-
tioxidants abound in the testis and semen, but cellular
damage can occur when homeostatic mechanisms are
perturbed. Excessive ROS have been detected in seminal
plasma and are produced by both sperm and neutrophils.
ROS production is directly measured by a chemilumines-
cence assay using luminol (5-amino-2,3-dihydro 1,4-
phthalazinedione) as the probe and assessed by a lumi-
nometer and reported as counted photons/min/U sperm
concentration.41 Because of their confounding effect on
OS measurements, it is critical to evaluate leukocyte
oncentrations in semen to determine the ROS contri-
ution by these cells. Seminal free radicals can also result
rom chronic disease, environmental exposures, infec-
ions, and immune responses. It is thought that excessive
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mROS damages sperm membranes, reduces sperm motility,
and induces sperm DNA damage.40 Although antioxi-
dant treatments may improve ROS balance, increases in
naturally pregnancy rates have not been as obviously
forthcoming. For these reasons, semen ROS levels are not
a commonly performed sperm function assay.40
Sperm Hyaluronic Acid Binding
It is clear that except for rare instances, such as globo-
zoospermia and multiflagellated forms, sperm shape does
not predict underlying chromosomal aneuploidy. Thus,
selection of sperm for ICSI by “normal” morphology does
not ensure the absence of chromosomal aneuploidy.42 A
sperm selection technique based on sperm membrane
binding to hyaluronic acid (HA), the main substrate of
the oocyte zona pellucida, could improve the likelihood
of obtaining chromosomally normal sperm for ICSI.
Noting an association between the presence of sperm
membrane HA receptors and various upstream features of
sperm maturity, Huszar et al.43 hypothesized that mature
perm would selectively bind to HA. They also surmised
hat sperm of diminished maturity have lower levels of
he 70-kd testis-expressed chaperone (HspA2), increased
hromosomal aberrations, and, because they have not
ndergone membrane remodeling, are unable to bind
o solid-state HA.43 Lastly, based on these attributes,
Huszar et al. postulated that HA binding would facil-
itate the selection of individual mature sperm with
lower levels of chromosomal aneuploidy.44 In addition,
armegiani et al. suggest that HA-selected ICSI sperm
roduce equivalent fertilization rates and good quality
mbryos compared with visually selected sperm, but
ay improve live baby rates substantially by decreasing
iscarriage rates.45
One limitation of this sperm selection technique is
that because sperm are firmly bound to HA, they must be
manually removed and cannot be obtained in suitable
numbers for IUI or IVF without ICSI. In addition, sub-
stantial clinical trial confirmation of these study findings
are lacking, including a precise definition of which pa-
tients will benefit most from this technology. However,
this technique, termed PICSI (“Physiological” ICSI), has
the potential to mimic sperm selection at the traditional
evolutionary level and may improve IVF/ICSI outcomes
in selected patients by reducing the abnormal paternal
contribution of sperm.45
Ultrafine Morphology
For 20 years, since the first report of a relationship be-
tween sperm morphology and IVF outcomes by Kruger,6
the value of sperm morphology as a predictor of preg-
nancy has been debated. Although correlating with IVF
success, the relationship between morphology and preg-
nancy success, either naturally or with IUI are, at best,
controversial associations.46 What is clear is that no
elationship exists between sperm strict morphology and
VF/ICSI outcomes.47 a
1032Based on the concept that there may be ultrastructural
features of sperm that could predict improved IVF/ICSI
outcomes but that are not currently detected by strict
morphology, Berkovitz et al. have proposed the exami-
nation of ultrafine sperm morphology.46 It might be that
the low power magnification (200x or 400x) used for
visual sperm selection for ICSI is relatively insensitive
and unable to detect subtle sperm organellar malforma-
tions that might affect pregnancy rates.46
To increase the “gain” on sperm morphology with the
goal of improving IVF/ICSI outcomes, Berkovitz and
colleagues developed a method for the detailed morpho-
logic evaluation of motile sperm in real time that is
termed MSOME (motile sperm organellar morphology
examination).46 MSOME is performed with an inverted
light microscope equipped with high-power Nomarski
optics enhanced by digital imaging to achieve a magni-
fication of 6300x (Fig. 4).46 In theory, the normalcy of
he sperm nucleus, as observed by MSOME, reflects
perm nuclear DNA content and organization, which in
urn could influence the outcomes of IVF/ICSI proce-
ures.46
Based on research with MSOME, Bartoov et al. intro-
duced a therapeutic procedure termed intracytoplasmic
morphologically selected sperm injection (IMSI).48 IMSI is
erformed in association with ICSI and uses MSOME
riteria to precisely select sperm with morphologically
ormal nuclei for ICSI. They have also shown that the
se of IMSI leads to significantly higher pregnancy rates
ompared with conventional IVF/ICSI in patients who
ave failed to achieve a clinical pregnancy in at least
hree IVF/ICSI cycles.49 The study design used by Bar-
oov’s group was able to exclude the special sperm prep-
ration technique needed for IMSI as the reason for
igher implantation and pregnancy rates and lower
iscarriage rates.50 Performing diagnostic MSOME or
therapeutic IMSI has several clinical limitations: (1)
significant time and effort is needed for IMSI, because
sperm selection can take several hours; (2) expertise
and training is needed for these techniques; and (3)
the cost of upgrading laboratory equipment to perform
IMSI is significant.50 Taking into account these issues,
Figure 4. Sperm ultrafine morphology. (A) Arrow delineates
a motile sperm with normal sperm nucleus by ultrafine
morphology (good contour, no vacuoles). (B) Arrows delin-
eate motile sperm with abnormal ultrafine morphology (ab-
normal contour or presence of vacuoles or both). Magnifi-
cation 6600x. (Courtesy Dr. Benjamin Bartoov.)diagnostic MSOME is advised in advance of IMSI to
UROLOGY 77 (5), 2011
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ICSI outcomes.
Chromatin Condensation and Sperm Epigenetics
The replacement of somatic histones by protamines is
important for sperm nuclear chromatin compaction,
sperm maturation and fertility.51 Condensation and sta-
ilization of sperm chromatin occurs in elongating sper-
atids, during epididymal transport, and with seminal
uid contact after ejaculation.52 Furthermore, chromatin
stability increases with time after ejaculation likely be-
cause of the formation of disulfide bridges.51 As a conse-
quence, mature sperm DNA is transcriptionally inactive.
During oocyte fertilization, the paternal genome is re-
stored to its transcriptionally active conformation. This is
accomplished through the chromatin decondensation
process characterized by the degradation of protamines,
the synthesis of histones, and binding of the histones to
DNA, leading to restoration of the paternal genome.51
A large variable in this process is that the histone to
protamine exchange process can be incomplete, with 5%
to 15% of the genome bound to nucleosomes.51 In hu-
mans, the proportion of protamine 1(P1) to protamine 2
(P2) is approximately 1:1, and changes to this ratio are
associated with altered sperm quality and decreased em-
bryo quality and IVF outcomes.53
Diagnostic tests now under development seek to de-
termine the quality of the sperm decondensation process
and its role in male infertility.53 Human sperm heads can
e decondensed in vitro using either oocytes from ani-
als (e.g., frog) or with detergents. However, precise
etermination of the degree of sperm head decondensa-
ion is time-consuming and time sensitive, because the
rocess is dynamic.54 Because of this, classification
schema that attempt to examine sperm decondensation
are subjective and imprecise.54 Despite this, attempts
ave been made to correlate the quality of sperm decon-
ensation with routine semen parameters, DNA integ-
ity, and IVF fertilization rates, but no consistent rela-
ionship has been observed.55 Thus, the role of diagnostic
perm nuclear decondensation in the male infertility
valuation is currently speculative.
CONCLUSIONS
In summary, older established tests of sperm function,
including morphology, do not necessarily deliver better
clinical information regarding the fertility potential of
sperm than that obtained from the semen analysis. In
addition, the relevance of many of these tests is question-
able with the wide acceptance of ICSI, a technique that
can bypass many abnormalities of sperm function. Newer
diagnostic tests of sperm function have more potential to
deliver clinically relevant information in the era of ICSI.
However, they require more extensive study to better un-
derstand their predictive role in reproductive medicine.
It is exciting to speculate how newer diagnostic tests of
sperm function relate to each other and to the older
UROLOGY 77 (5), 2011assays. For example, will ultrafine morphology be the
physical correlate of abnormal sperm chromatin packag-
ing and DNA fragmentation? Will sperm chromatin de-
condensation tests correlate with the SPA in some way,
and does the HA-binding assay reflect similar findings as
the HZA assay? The development of such assays should
be encouraged in the future to rationalize clinical deci-
sion-making in the heavily technological field of human
reproductive medicine.
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